Toronto Bioscience Company
Toronto Bioscience treats diabetes, obesity, cancer, and cardiovascular disease. They develop and manufacture their ELISA kits, immuno-turbulence assays, antibodies, and recombinant proteins following quality standards. They offer services that are now used for clinical, diagnostic, and research purposes.
Industry:
Biomarkers for Longevity
Headquarters:
Toronto, Ontario, Canada
Zip:
11-50
Founded Date:
2012-01-01
Employees Number:
11-50
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Type:
sales@torontobioscience.com
Register and Claim Ownership